CymitQuimica logo

CAS 286930-03-8

:

Fesoterodine fumarate

Description:
Fesoterodine fumarate is a pharmaceutical compound primarily used as an antimuscarinic agent for the treatment of overactive bladder. It is a prodrug that is metabolized into its active form, 5-hydroxymethyl tolterodine, which selectively inhibits muscarinic receptors in the bladder, thereby reducing involuntary contractions and increasing bladder capacity. The substance is typically administered orally and is known for its relatively favorable side effect profile compared to other anticholinergic medications. Fesoterodine fumarate is characterized by its solubility in water and organic solvents, which facilitates its absorption in the gastrointestinal tract. The compound's molecular structure includes a fumarate salt, enhancing its stability and bioavailability. Common side effects may include dry mouth, constipation, and dizziness, which are typical of anticholinergic drugs. As with any medication, it is essential to use fesoterodine fumarate under medical supervision to ensure appropriate dosing and to monitor for potential adverse effects.
Formula:C26H37NO3·C4H4O4
InChI:InChI=1/C26H37NO3.C4H4O4/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6;5-3(6)1-2-4(7)8/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t23-;/m1./s1
SMILES:[C@H](CCN(C(C)C)C(C)C)(C1=C(OC(C(C)C)=O)C=CC(CO)=C1)C2=CC=CC=C2.C(=C/C(O)=O)\C(O)=O
Synonyms:
  • (R)-Fesoterodine fumarate
  • 2-((1R)-3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate
  • Fesoterodine Fumarate
  • Propanoic acid, 2-methyl-, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl ester, (2E)-2-butenedioate (1:1)
  • Propanoic acid, 2-methyl-, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl ester, (2E)-2-butenedioate (1:1) (salt)
  • Smp 8272
  • Spm 8272
  • Spm 907
  • Toviaz
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 13 products.